|Issuer:||PMV PHARMACEUTICALS, INC. (PMVP)|
|Original Submission Date:|
LEVINE ARNOLD J
C/O PMV PHARMACEUTICALS, INC.
8 CLARKE DRIVE, SUITE 3 CRANBURY, NJ 08512
|Title of Security||Transaction Date||2a. Deemed Execution Date||Transaction Code||Shares||Acquired or Disposed||Price per share||5. Amount of Securities Beneficially Owned Following Reported Transaction||6. Ownership Form Direct or Indirect||Nature of Indirect Ownership|
|Title of Derivative Security||Conversion or Exercise Price of Derivative Security||Transaction Date||Deemed Execution Date||Transaction Code||Number of Derivative Securities Acquired (A) or Disposed of (D)||Date Exercisable||Expiration Date||Title and Amount of Securities Underlying Derivative Security||Price of Derivative Security||Number of derivative Securities Beneficially Owned Following Reported Transaction(s)||Ownership Form: Direct (D) or Indirect (I)||Nature of Indirect Beneficial Ownership|
|f1||the sale reported in this form 4 was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on march 27, 2021.|